Execution of Human papillomavirus (HPV) vaccination at large in India

Not yet recruiting

• Conditions: HPV vaccine/vaccination stakeholders (irrespective of their health status)

• Registration Number: CTRI/2022/06/043233
• Lead Sponsor: Prasanna School of Public Health

Brief Summary

Cervical cancer is a major public health issue in India, resulting in a significant economic burden that is carried disproportionately by patients as out-of-pocket expenses (OOPE). The burden of cervical cancer is so high that it contributes about 122,844 cervical cancer every year. To halt these rising statistics, vaccination against the infection can curb the escalating cervical cancer as one of the preventive methods. Unfortunately, due to various circumstances, India struggles to deliver the Human papillomavirus (HPV) vaccine at scale. To provide this promising approach and develop a roadmap of activities in eliminating cervical cancer, it is indispensable to capture the stakeholders’ viewpoints of the HPV vaccine. Therefore, this study intended to include all the stakeholders of vaccination to capture their perspectives regarding the implementation of the HPV vaccine, which will aid a policy review in developing a roadmap of activities to eliminate cervical cancer as a public health issue from India. Policymakers and health service providers will be included to seek input on how introducing the HPV vaccine would impact current services and systems, which will supplement in formulating the roadmap activities for eliminating cervical cancer as a significant public health issue.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-06-20
• Last Update Posted: 2022-07-06

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• HPV Vaccine/stakeholders 2.

• 18 years 3.

• Able to understand and respond in English, Hindi, Assamese, or Nagamese.
• Biological material required: No.

Exclusion Criteria

Parents/guardians who have only male children.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
A.Develop an action plan to implement HPV vaccination at scale in India	At the baseline

Secondary Outcome Measures

Name	Time	Method
B. Identify a range of knowledge, attitude, beliefs, perceived need among HPV vaccine stakeholders regarding the HPV vaccination implementation in India	At the baseline

Trial Locations

Locations (1)

Kasturba Hospital, Manipal; 🇮🇳 Udupi, KARNATAKA, India

Kasturba Hospital, Manipal

🇮🇳Udupi, KARNATAKA, India

Priyobrat Rajkhowa

Principal investigator

9508549619

priyobratrajkhowa.11@gmail.com